Reactions of Polylysine with Human Platelets in Plasma and in Suspensions of Washed Platelets^[*]

Summary

The effects of polylysine on human platelets have been examined in citrated platelet-rich plasma (PRP) and in suspensions of washed platelets in various media. In PRP, polylysine caused aggregation after a lag phase. Heparin inhibited this completely. At certain concentrations of polylysine, two phases of aggregation occurred, the second being associated with release of ¹⁴C-serotonin from prelabelled platelets; this phase was inhibitable with prostaglandin E₁, acetylsalicylic acid, sulphinpyrazone, adenosine, apyrase, or creatine phos- phate/creatine phosphokinase. Polylysine-induced release also occurred in PRP with EDTA or hirudin as anticoagulant. In suspensions of washed platelets in Tyrode solution containing 0.35% or 4% albumin, or 1% gelatin, polylysine caused immediate platelet-to-platelet adherence and very little release of ¹⁴C-serotonin or platelet lysis. Heparin inhibited aggregation, but acetylsalicylic acid, prostaglandin E₁, adenosine, apyrase, creatine phosphate/creatine phosphokinase or EDTA did not. In a modified Tyrode-albumin medium containing 1 mM magnesium but no calcium, polylysine-induced aggregation was associated with the release of ¹⁴C-serotonin which could be inhibited by acetylsalicylic acid or indomethacin; this is similar to the effect of ADP in this medium. In Tyrode solution without albumin or gelatin, polylysine-induced platelet aggregation was associated with release of a large percentage of ¹⁴C-serotonin, together with as much as 18% lysis; indomethacin inhibited this release reaction.

• References

• 1 Emmons P. R, Hampton J. R, Harrison M. J. G, Honour A. J, Mitchell J. R. A. 1967; Effect of prostaglandin E₁ on platelet behaviour in vitro and in vivo. British Medical Journal 2: 468.
• 2 Gröttum K. A. 1969; Platelet surface charge and aggregation: Effects of polyelectrolytes. Thrombosis et Diathesis Haemorrhagica 21: 450.
• 3 Hamberg M, Svensson J, Samuelsson B. 1974; Prostaglandin endoperoxides. A new concept concerning the mode of action and release of prostaglandins. Proceedings of the National Academy of Sciences, U.S.A 71: 3828.
• 4 Hamberg M, Svensson J, Samuelsson B. 1975; Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides. Proceedings of the National Academy of Sciences, U.S.A 72: 2994.
• 5 Holmsen H, Day H. J, Stormorken H. 1969; The blood platelet release reaction. Scandinavian Journal of Haematology Suppl. 8: 1.
• 6 Jenkins C. S. P, Packham M. A, Kinlough-Rathbone R. L, Mustard J. F. 1971; Interactions of polylysine with platelets. Blood 37: 395.
• 7 Kinlough-Rathbone R. L, Packham M. A, Mustard J. F. 1970; The effect of prostaglandin E₁ on platelet function in vitro and in vivo. British Journal of Haematology 19: 559.
• 8 Kloeze J. 1967. Influence of prostaglandins on platelet adhesiveness and platelet aggregation. In: Bergstrom S, Samuelsson B. (eds.), Proceedings of 2nd Nobel Symposium, Stockholm, June 1966.. Almqvist and Wiksell; Stockholm: Interscience, New York 241.
• 9 Lalezari P, Spaet T.H. 1961; Antiheparin and hemagglutinating activities of polybrene. Journal of Laboratory and Clinical Medicine 57: 868.
• 10 Massini P, Lüscher E. F. 1972; On the mechanism by which cell contact induces the release reaction of blood platelets: The effect of cationic polymers. Thrombosis et Diathesis Haemorrhagica 27: 121.
• 11 Massini P, Metcalf L.C, Näf U, Lüscher E. F. 1974; Induction of aggregation and of the release reaction in human platelets by polylysine. Haemostasis 3: 8.
• 12 Macfarlane D. E, Walsh P. N, Mills D. C. B, Holmsen H, Day H. J. 1975; The role of thrombin in ADP-induced platelet aggregation and release: a critical evaluation. British Journal of Haematology 30: 457.
• 13 Molnar J, Lorand L. 1961; Studies on apyrases. Archives of Biochemistry and Biophysics 93: 353.
• 14 Mustard J. F, Perry D. W, Ardlie N. G, Packham M. A. 1972; Preparation of suspensions of washed platelets from humans. British Journal of Haematology 22: 193.
• 15 Mustard J. F, Perry D. W, Kinlough-Rathbone R. L, Packham M. A. 1975; Factors responsible for ADP-induced release reaction of human platelets. American Journal of Physiology 228: 1757.
• 16 Packham M. A, Warrior E. S, Glynn M. F, Senyi A. S, Mustard J. F. 1967; Alteration of the response of platelets to surface stimuli by pyrazole compounds. Journal of Experimental Medicine 126: 171.
• 17 Schneider W, Kübler W, Gross R. 1968; Induction of blood platelet aggregation by cationic polypeptides. Thrombosis et Diathesis Haemorrhagica 19: 307.
• 18 Sheppard G, Marlow C. G. 1971; The stimultaneous measurement of ⁵¹Cr and ¹⁴C by liquid scintillation counting. International Journal of Applied Radiation and Isotopes 22: 125.
• 19 Smith J. B, Ingerman C, Kocsis J. J, Silver M. J. 1974; Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. Journal of Clinical Investigation 53: 1468.
• 20 Vainer H, Jeanneau C, Booyse F. M, Wassermann N. 1971. Platelet-polyelectrolytes interactions. Some properties of the polylysine induced platelet aggregation. Possible correlations with the surface located contractile protein. In: Caen J. (ed.), Platelet Aggregation. Masson et Cie; Paris: 137.
• 21 White J. G. 1972; Effects of cationic polypeptides on thrombasthenic and afibrinogenemic blood platelets. American Journal of Pathology 68: 447.
• 22 Willis A. L, Kuhn D. C. 1973; A new potential mediator of arterial thrombosis whose biosynthesis is inhibited by aspirin. Prostaglandins 4: 127.
• 23 Zucker M. B, Peterson J. 1968; Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion. Proceedings of the Society for Experimental Biology and Medicine 127: 547.